GIST

>

Latest News

Antitumor Activity Seen With Olverembatinib in TKI-Resistant SDH-Deficient GIST
Antitumor Activity Seen With Olverembatinib in TKI-Resistant SDH-Deficient GIST

June 4th 2024

A promising new treatment option has emerged for patients with a specific type of gastrointestinal stromal tumor that has become resistant to standard therapy.

Promising Research to Advance Treatment of Gastrointestinal Stromal Tumors
Promising Research to Advance Treatment of Gastrointestinal Stromal Tumors

September 4th 2023

FDA Approves First Avapritinib CDx for PDGFRA Exon 18 Detection
FDA Approves First Avapritinib CDx for PDGFRA Exon 18 Detection

August 8th 2023

Bezuclastinib/Sunitinib Shows Early Promise in Second-Line GIST
Bezuclastinib/Sunitinib Shows Early Promise in Second-Line GIST

August 1st 2023

VOYAGER Trial Shows Potential of ctDNA Analysis in GIST
VOYAGER Trial Shows Potential of ctDNA Analysis in GIST

July 30th 2023

Video Series
Video Interviews

More News